ConductScience.org, home

Paper13633822

[Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843].

DELAY J and 5 others. Presse Med (1893), 1959. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. [Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843]. Papers, record 13633822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13633822

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843].
PubMed
Journal
Presse Med (1893)
PubMed
Year
1959
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
29
iCite
Revised in PubMed
2018-12-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1DELAY JJ
2DENIKER PP
3ROBERT RR
4BEEK HH
5BARANDE RR
6EURIEULT MM

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Nervous System DiseasesMajor topic
SulfonamidesMajor topic
SyndromeMajor topic
Humans
Phenothiazines
Sulfanilamide
Sulfanilamides

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
14195882AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.Proc R Soc Med1964https://conductscience.org/library/papers/14195882PubMed
14190465SOME PHARMACOLOGICAL PROPERTIES OF THIOPROPERAZINE AND THEIR MODIFICATION BY ANTI-PARKINSONIAN DRUGS.Br J Pharmacol Chemother1964https://conductscience.org/library/papers/14190465PubMed
14048558THIOPROPERAZINE: A STUDY OF ITS USE IN PSYCHOTIC EXCITATION.Psychopharmacologia1963https://conductscience.org/library/papers/14048558PubMed
14048548CLINICAL EXPERIENCES WITH THIOPROPERAZINE ("MAJEPTIL") IN CHRONIC SCHIZOPHRENIA, PSYCHOTIC EXCITATION, AND SENILE AGITATION.Psychopharmacologia1963https://conductscience.org/library/papers/14048548PubMed
13921525[On the treatment of acute excitation states in endogenous psychoses].Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr1962https://conductscience.org/library/papers/13921525PubMed
706The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.Psychopharmacologia1975https://conductscience.org/library/papers/706PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/13633822

GET https://conductscience.org/api/papers/v1/13633822/authors